Overall, the Opa1 and Mfn2 levels were intended to be lower in hyperglycemic ischemia than in normoglycemic ischemia and deletion of UCP2 affected these fusion markers in normoglycemic ischemic mice. This evidence concerns the gene UCP2 and ischemia.